Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Nemours Children's Clinic
- Study ID
- NCT05280184
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 11 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Coin2Dose — BEHAVIORALBehavioral Economics incentive intervention that also combines automated text message reminders to dose for insulin
Study Details
Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.
Key Dates
- Start date
- Jan 1, 2023
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2025
- Completion
- Sep 30, 2025
Study Design
- Enrollment
- 173 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Coin2DoseBEI intervention that also combines automated text message reminders to dose for insulin; will test Contingent and Non-Contingent BEI
- No Intervention: Standard Care ControlStandard care control group; will not receive automated text message reminders to dose for insulin nor BEI for daily BOLUS scores
Primary Outcome Measure
Change in Glycated Hemoglobin- HbA1c [ Time Frame: change in week 0 outcome at week 13 ]
Locations (2)
| Facility | City | State | ZIP |
|---|---|---|---|
| Nemours Children's Health | Jacksonville | Florida | 32207 |
| Children's Mercy Kansas City | Kansas City | Missouri | 64108 |
Find similar trials in Jacksonville, FL
By condition
By specialty
Related Studies
- Lipoprotein Kinetics in T1DRecruiting · University of Missouri-Columbia · Columbia, Missouri
- Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age FamiliesRecruiting · Nemours Children's Clinic · Jacksonville, Florida
- Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 DiabetesPHASE1/PHASE2 · Recruiting · Creative Medical Technology Holdings Inc · Miami, Florida
- Immune Function and the Progression to T1DRecruiting · University of Florida · Gainesville, Florida